Drug
Dapagliflozin 10 MG Oral Tablet [Farxiga]
Dapagliflozin 10 MG Oral Tablet [Farxiga] is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_4
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Active, not recruiting1
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 31 (33.3%)
Phase 42 (66.7%)
Trials by Status
active_not_recruiting133%
unknown133%
recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingphase_3
Dapagliflozin for Cardio-renal Protection After ICU Discharge
NCT07025629
active_not_recruitingphase_4
proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2
NCT05590143
unknownphase_4
Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
NCT03887416
Clinical Trials (3)
Showing 3 of 3 trials
NCT07025629Phase 3
Dapagliflozin for Cardio-renal Protection After ICU Discharge
NCT05590143Phase 4
proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2
NCT03887416Phase 4
Effect of Dapagliflozin on Nighttime Blood Pressure in Type 2 Diabetes
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3